EXACT Therapeutics is a clinical stage biotech firm developing a technology platform for therapeutic enhancement Acoustic Cluster Therapy.
EXACT Therapeutics has raised $13.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2024.
EXACT Therapeutics's investors include Investinor, BaseN, Sundt AS, Helene Sundt, Anders Wold.
EXACT Therapeutics is headquartered in Oslo, Norway.
EXACT Therapeutics is a clinical stage biotech firm developing a technology platform for therapeutic enhancement Acoustic Cluster Therapy.
EXACT Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EXACT Therapeutics — Funding & Investors." VCBacked, December 3, 2024, https://www.vcbacked.co/company/exact-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). EXACT Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/exact-therapeutics
{{cite web |title=EXACT Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/exact-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated